Spatial proximity of CD8 T cells to tumor cells as an independent biomarker for response to anti-PD-1 therapy.

Authors

null

Maarten Slagter

Netherlands Cancer Institute, Amsterdam, Netherlands

Maarten Slagter , Elisa A. Rozeman , Huiwen Ding , Judith M. Versluis , Mesele Valenti , Dennis Peters , Annegien Broeks , Charlotte van Rooijen , Hugo Horlings , John B. A. G. Haanen , Erik Hooijberg , Lodewyk F. A. Wessels , Christian U. Blank , Ton N. Schumacher

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Session

Session Title

Melanoma/Skin Cancers

Track

Melanoma/Skin Cancers

Sub Track

Advanced/Metastatic Disease

Citation

J Clin Oncol 38: 2020 (suppl; abstr 10038)

DOI

10.1200/JCO.2020.38.15_suppl.10038

Abstract #

10038

Poster Bd #

387

Abstract Disclosures

Similar Posters

First Author: Maud Rijnders

First Author: Alberto Carretero-Gonzalez

Poster

2017 ASCO-SITC Clinical Immuno-Oncology Symposium

Phase I study with pegylated human IL-10 (AM0010) alone or in combination with anti-PD-1 or FOLFOX-immune biomarker update.

Phase I study with pegylated human IL-10 (AM0010) alone or in combination with anti-PD-1 or FOLFOX-immune biomarker update.

First Author: Aung Naing

First Author: Nicole Grace Chau